Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar flyingchai (< 20) Submitted: 7/29/2010 10:45:53 AM : Outperform Start Price: $4.90 ALTH Score: -82.94

Promising drug data for folotyn!

Report this Post Reply

Featured Broker Partners


Advertisement